$19.26
1.53% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US45781M1018
Symbol
INVA

Innoviva Target price 2024 - Analyst rating & recommendation

Innoviva Classifications & Recommendation:

Buy
50%
Hold
50%

Innoviva Price Target

Target Price $18.00
Price $19.26
Deviation
Number of Estimates 1
1 Analyst has issued a Innoviva price target 2025. The average Innoviva target price is $18.00. This is lower than the current stock price.
A rating was issued by 2 analysts: 1 Analysts recommend Innoviva to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Innoviva stock has an average upside potential 2025 of . Most analysts recommend the Innoviva stock at Buy or hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 324.26 338.61
6.06% 4.43%
EBITDA Margin 46.13% 53.19%
29.70% 15.30%
Net Margin 42.44% 9.79%
1.19% 76.93%

2 Analysts have issued a sales forecast Innoviva 2024 . The average Innoviva sales estimate is

$339m
Unlock
. This is
1.65% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$342m 0.63%
Unlock
, the lowest is
$335m 2.67%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $324m 6.06%
2024
$339m 4.43%
Unlock
2025
$341m 0.57%
Unlock
2026
$369m 8.32%
Unlock
2027
$395m 7.05%
Unlock
2028
$477m 20.66%
Unlock

1 Analyst has issued an EBITDA forecast Innoviva 2024 . The average Innoviva EBITDA estimate is

$180m
Unlock
. This is
2.44% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$180m 2.44%
Unlock
, the lowest is
$180m 2.44%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $150m 33.96%
2024
$180m 20.40%
Unlock
2025
$162m 10.33%
Unlock
2026
$164m 1.58%
Unlock

EBITDA Margin

2023 46.13% 29.70%
2024
53.19% 15.30%
Unlock
2025
47.43% 10.83%
Unlock
2026
44.47% 6.24%
Unlock

2 Innoviva Analysts have issued a net profit forecast 2024. The average Innoviva net profit estimate is

$33.2m
Unlock
. This is
67.88% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$35.0m 66.06%
Unlock
, the lowest is
$31.3m 69.70%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $138m 7.17%
2024
$33.2m 75.91%
Unlock
2025
$71.3m 115.08%
Unlock
2026
$81.6m 14.47%
Unlock
2027
$95.7m 17.25%
Unlock
2028
$127m 32.68%
Unlock

Net Margin

2023 42.44% 1.19%
2024
9.79% 76.93%
Unlock
2025
20.94% 113.89%
Unlock
2026
22.13% 5.68%
Unlock
2027
24.24% 9.53%
Unlock
2028
26.65% 9.94%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 2.20 0.53
7.17% 75.91%
P/E 36.34
EV/Sales 4.25

2 Analysts have issued a Innoviva forecast for earnings per share. The average Innoviva <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.53
Unlock
. This is
67.88% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.56 66.06%
Unlock
, the lowest is
$0.50 69.70%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $2.20 7.17%
2024
$0.53 75.91%
Unlock
2025
$1.14 115.09%
Unlock
2026
$1.31 14.91%
Unlock
2027
$1.53 16.79%
Unlock
2028
$2.03 32.68%
Unlock

P/E ratio

Current 11.65 113.76%
2024
36.34 211.93%
Unlock
2025
16.89 53.52%
Unlock
2026
14.76 12.61%
Unlock
2027
12.59 14.70%
Unlock
2028
9.49 24.62%
Unlock

Based on analysts' sales estimates for 2024, the Innoviva stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.18 10.88%
2024
4.25 1.65%
Unlock
2025
4.22 0.57%
Unlock
2026
3.90 7.68%
Unlock
2027
3.64 6.59%
Unlock
2028
3.02 17.13%
Unlock

P/S ratio

Current 3.50 32.77%
2024
3.56 1.68%
Unlock
2025
3.54 0.56%
Unlock
2026
3.27 7.68%
Unlock
2027
3.05 6.59%
Unlock
2028
2.53 17.12%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today